结肠镜远端附件装置提高腺瘤检出率的比较疗效:一项网络荟萃分析
该网络荟萃分析检索截至2017年3月的PubMed/Medline和Embase数据库,纳入25项随机对照试验(共16103例患者),比较cap、Endocuff和Endorings等远端附件装置与标准结肠镜的腺瘤检出率。结果显示远端附件装置总体较标准结肠镜提高腺瘤检出率(RR 1.13,95%CI 1.03-1.23,低质量证据),Endocuff较标准结肠镜提高腺瘤检出率(RR 1.21,95%CI 1.03-1.41,低质量证据);Endorings和cap的证据质量极低。
要点
- 远端附件装置总体较标准结肠镜提高腺瘤检出率(RR 1.13,95%CI 1.03-1.23,低质量证据)。
- Endocuff较标准结肠镜提高腺瘤检出率(RR 1.21,95%CI 1.03-1.41,低质量证据)。
- Endorings(RR 1.70,95%CI 0.86-3.36)和cap(RR 1.07,95%CI 0.96-1.19)证据质量极低。
核心结论
- 基于网络荟萃分析,远端附件装置对腺瘤检出率的改善预期仅为中等程度,在低水平内镜医师中尤其如此。
研究设计与样本
- 检索PubMed/Medline和Embase数据库截至2017年3月,纳入25项随机对照试验(共16103例患者),比较cap、Endocuff和Endorings等远端附件装置彼此之间或与标准结肠镜的疗效。
- 主要结局为腺瘤检出率,次要结局包括息肉检出率、盲肠插管率和盲肠插管时间;采用配对和网络荟萃分析,并使用推荐分级的评估、制定与评价(GRADE)方法评估证据质量。
主要发现
- 总体而言,远端附件装置较标准结肠镜提高腺瘤检出率(RR 1.13,95%CI 1.03-1.23,低质量证据),低水平内镜医师(基线腺瘤检出率10%)的腺瘤检出率潜在绝对增加至11.3%,高水平内镜医师(基线腺瘤检出率40%)增加至45.2%。
- 比较评估中,低质量证据显示Endocuff较标准结肠镜提高腺瘤检出率(RR 1.21,95%CI 1.03-1.41),低水平内镜医师的腺瘤检出率预期增加至12%,高水平内镜医师增加至48%。
- 极低质量证据支持Endorings(RR 1.70,95%CI 0.86-3.36)或cap(RR 1.07,95%CI 0.96-1.19)较标准结肠镜提高腺瘤检出率。
- 由于证据质量极低,一种远端附件装置优于另一种的获益尚不确定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 远端附件装置总体比较为低质量证据,Endocuff比较为低质量证据。
- Endorings和cap比较为极低质量证据。
- 一种远端附件装置优于另一种的获益因极低质量证据而不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Several add-on devices have been developed to increase rates of colon adenoma detection (ADR). We assessed their overall and comparative efficacy, and estimated absolute magnitude of benefit through a network meta-analysis. METHODS: We searched the PubMed/Medline and Embase database through March 2017 and identified 25 randomized controlled trials (comprising 16,103 patients) that compared the efficacy of add-on devices (cap; Endocuff; Arc Medical Design Ltd, Leeds, UK, and Endorings; Us Endoscopy, Mentor, OH) with each other or with standard colonoscopy. The primary outcome was ADR; secondary outcomes included rate of polyp detection, and rate of and time to cecal intubation. We performed pairwise and network meta-analyses, and appraised quality of evidence using Grading of Recommendations Assessment, Development and Evaluation. We estimated the magnitude of increase in ADR by low-performing endoscopists (baseline ADR, 10%) and high-performing endoscopists (baseline ADR, 40%) with use of these devices. RESULTS: Overall, distal attachment devices increased ADR compared with standard colonoscopy (relative risk [RR], 1.13; 95% CI, 1.03-1.23; low-quality evidence), with potential absolute increases in ADR to 11.3% for low-performing endoscopists and to 45.2% for high-performing endoscopists. In a comparative evaluation, we found low-quality evidence that Endocuff increases ADR compared with standard colonoscopy (RR, 1.21; 95% CI, 1.03-1.41), with anticipated increases in ADR to 12% for low-performing endoscopists and to 48% for high-performing endoscopists. We found very low quality evidence to support the use of Endorings (RR, 1.70; 95% CI, 0.86-3.36) or caps (RR, 1.07; 95% CI, 0.96-1.19) vs standard colonoscopy for increasing ADR. The benefit of one distal attachment device over another was uncertain due to very low quality evidence. CONCLUSIONS: Based on network meta-analysis, we anticipate only modest improvement in ADRs with use of distal attachment devices, especially in low-performing endoscopists.
引用
- Facciorusso A, Del Prete V, Buccino RV, et al. Comparative Efficacy of Colonoscope Distal Attachment Devices in Increasing Rates of Adenoma Detection: A Network Meta-analysis. Clin Gastroenterol Hepatol. 2017. PMID: 29133257. doi:10.1016/j.cgh.2017.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。